This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2023!
8-11 May 2023RAI in Amsterdam

Mark Duerkop
Chief Executive Officer at Novasign

Profile

Dr. Mark Duerkop is co-founder and CEO of Novasign GmbH a spin-off from the University of Natural Resources and Life Sciences in Vienna focusing on accelerating bioprocess development by application of advanced machine learning tools. Within the last years Mark developed a hybrid modeling software with his team that help bioprocess engineers to better understand their processes while additionally reducing the experimental effort to find process optima.

Agenda Sessions

  • Chairperson’s Opening Remarks

    08:20
  • Chairperson's Remarks

    13:10
  • Accelerating upstream development timelines by combining hybrid modelling and advanced design space screening methods

    13:45
  • Chairperson's Remarks

    13:25

Speakers at this event